Matches in Wikidata for { <http://www.wikidata.org/entity/Q90981511> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q90981511 description "artículu científicu espublizáu en xunetu de 2019" @default.
- Q90981511 description "scientific article published on 06 July 2019" @default.
- Q90981511 description "wetenschappelijk artikel" @default.
- Q90981511 description "наукова стаття, опублікована 6 липня 2019" @default.
- Q90981511 name "Evolution of B-type natriuretic peptide and N-terminal pro-brain natriuretic peptide during acute decompensated heart failure in a chronic heart failure patient with reduced ejection fraction treated with Sacubitril/Valsartan: a case report" @default.
- Q90981511 name "Evolution of B-type natriuretic peptide and N-terminal pro-brain natriuretic peptide during acute decompensated heart failure in a chronic heart failure patient with reduced ejection fraction treated with Sacubitril/Valsartan: a case report" @default.
- Q90981511 type Item @default.
- Q90981511 label "Evolution of B-type natriuretic peptide and N-terminal pro-brain natriuretic peptide during acute decompensated heart failure in a chronic heart failure patient with reduced ejection fraction treated with Sacubitril/Valsartan: a case report" @default.
- Q90981511 label "Evolution of B-type natriuretic peptide and N-terminal pro-brain natriuretic peptide during acute decompensated heart failure in a chronic heart failure patient with reduced ejection fraction treated with Sacubitril/Valsartan: a case report" @default.
- Q90981511 prefLabel "Evolution of B-type natriuretic peptide and N-terminal pro-brain natriuretic peptide during acute decompensated heart failure in a chronic heart failure patient with reduced ejection fraction treated with Sacubitril/Valsartan: a case report" @default.
- Q90981511 prefLabel "Evolution of B-type natriuretic peptide and N-terminal pro-brain natriuretic peptide during acute decompensated heart failure in a chronic heart failure patient with reduced ejection fraction treated with Sacubitril/Valsartan: a case report" @default.
- Q90981511 P1433 Q90981511-14D37D25-9167-4A85-A1DE-81A9167C61AE @default.
- Q90981511 P1476 Q90981511-F72441F7-B094-460F-8CB2-9C9F2B06ACB5 @default.
- Q90981511 P2093 Q90981511-73C95692-8F12-4351-AADC-CF0D9C88AEA6 @default.
- Q90981511 P2093 Q90981511-8FA33BF1-2A5D-42AB-BF83-0F62DC96B9E8 @default.
- Q90981511 P2093 Q90981511-F506019C-3CBC-4742-8A30-A053CCCD8D16 @default.
- Q90981511 P275 Q90981511-a7b2968f-b3c9-4b5a-96c7-25ea7d3c9fb3 @default.
- Q90981511 P304 Q90981511-6EA40888-C4C8-4134-9005-00E07781DDFF @default.
- Q90981511 P31 Q90981511-1FE1898D-3177-4A1C-B65C-339DA1F41771 @default.
- Q90981511 P31 Q90981511-421d094f-c62a-414b-9499-93bd5b9f8000 @default.
- Q90981511 P356 Q90981511-4CC735DC-33AA-49E2-BB66-EE28378A12BD @default.
- Q90981511 P433 Q90981511-959AC1E1-42AF-4539-8DEF-8ADC922FB1B6 @default.
- Q90981511 P478 Q90981511-C25D4EA9-5133-4C38-A185-D3B7B191D478 @default.
- Q90981511 P50 Q90981511-09C7748F-B05F-48DF-B9E2-B9E0A10EE38F @default.
- Q90981511 P50 Q90981511-6F5CD01B-31C3-4D0D-9F1E-EF1F341FA30F @default.
- Q90981511 P50 Q90981511-DABF4E1B-C925-4940-A044-93D61A8D8626 @default.
- Q90981511 P577 Q90981511-1A3A2BF0-D209-4EF8-81DA-48D317EB8858 @default.
- Q90981511 P6216 Q90981511-486b7b2e-0fc4-40cc-9cb8-b396653848dc @default.
- Q90981511 P698 Q90981511-776D7045-1547-4275-9276-9588701A716F @default.
- Q90981511 P921 Q90981511-1836213C-0668-4A94-A608-235B3B612939 @default.
- Q90981511 P921 Q90981511-1904B5ED-FF78-4861-8003-AAF81A1DC74F @default.
- Q90981511 P921 Q90981511-91311003-457E-4194-B364-B0564F8E9E10 @default.
- Q90981511 P921 Q90981511-F27C588B-ED44-499F-8B9B-0F9AB3CAAC9D @default.
- Q90981511 P932 Q90981511-9ED27832-1534-439A-BA64-631AF78A3FBF @default.
- Q90981511 P356 YTZ108 @default.
- Q90981511 P698 31660484 @default.
- Q90981511 P1433 Q68835761 @default.
- Q90981511 P1476 "Evolution of B-type natriuretic peptide and N-terminal pro-brain natriuretic peptide during acute decompensated heart failure in a chronic heart failure patient with reduced ejection fraction treated with Sacubitril/Valsartan: a case report" @default.
- Q90981511 P2093 "Alexandre Mebazaa" @default.
- Q90981511 P2093 "Hélène Nougué" @default.
- Q90981511 P2093 "Jean-Marie Launay" @default.
- Q90981511 P275 Q34179348 @default.
- Q90981511 P304 "ytz108" @default.
- Q90981511 P31 Q13442814 @default.
- Q90981511 P31 Q2782326 @default.
- Q90981511 P356 "10.1093/EHJCR/YTZ108" @default.
- Q90981511 P433 "3" @default.
- Q90981511 P478 "3" @default.
- Q90981511 P50 Q43175778 @default.
- Q90981511 P50 Q90437823 @default.
- Q90981511 P50 Q90981506 @default.
- Q90981511 P577 "2019-07-06T00:00:00Z" @default.
- Q90981511 P6216 Q50423863 @default.
- Q90981511 P698 "31660484" @default.
- Q90981511 P921 Q11829287 @default.
- Q90981511 P921 Q181754 @default.
- Q90981511 P921 Q4677930 @default.
- Q90981511 P921 Q641303 @default.
- Q90981511 P932 "6764567" @default.